Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 55,579 | 34,996 | 25,671 | 22,207 | 20,047 |
| Cost of Goods | 4,650 | 3,155 | 2,539 | 2,001 | 2,040 |
| Gross Profit | 50,929 | 31,841 | 23,132 | 20,206 | 18,007 |
| Operating Expenses | 139,502 | 104,658 | 109,675 | 97,531 | 87,188 |
| Operating Income | -87,923 | -72,662 | -86,004 | -77,324 | -69,141 |
| Other Income | 1,320 | 548 | 270 | 393 | 421 |
| Pre-tax Income | -86,603 | -72,114 | -85,734 | -76,931 | -68,720 |
| Income Tax | N/A | 5 | 0 | -23 | 24 |
| Net Income Continuous | -86,603 | -72,119 | -85,734 | -76,908 | -68,744 |
| Net Income | $-86,603 | $-72,119 | $-85,734 | $-76,908 | $-68,744 |
| EPS Basic Total Ops | -0.92 | -0.78 | -1.05 | -0.95 | -0.85 |
| EPS Basic Continuous Ops | -0.92 | -0.78 | -1.05 | -0.95 | -0.85 |
| EPS Diluted Total Ops | -0.92 | -0.78 | -1.05 | -0.95 | -0.85 |
| EPS Diluted Continuous Ops | -0.92 | -0.78 | -1.05 | -0.95 | -0.85 |
| EBITDA(a) | $-84,619 | $-76,570 | $-86,637 | $-78,783 | $-69,637 |